uniQure N.V. (QURE) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Thank you for standing by. My name is Kate and I will be your conference operator today. At this time, I would like to welcome everyone to the Unicure fourth quarter and year end 2025 earnings call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you would like to ask a question during this time, simply press star followed with the number one on your telephone keypad. If you would like to withdraw your question, press star one again. Thank you. I would now like to turn the call over to Cara Rosso, Senior Director of Investor Relations. Please go ahead. Good morning, and thank you for joining us for Unicure's year-end 2025 earnings call. Earlier this morning, Unicure released its financial results for the fourth quarter and year-end of 2025, and our press release is available on the Investors and Media section of our website, at unicure.com. Our 10K was also filed with the SEC earlier this morning. Joining me on the call this morning are Matt Capista, Chief Executive Officer, Dr. Wally Abisab, Chief Medical Officer, Kylie O'Keefe, Chief Customer and Strategy Officer, and Christian Klempt, Chief Financial Officer. After our formal remarks, we'll open up the call for Q&A. Before we begin, please know that we will be making forward-looking statements during this investor call. All statements, other than statements of historical fact, are forward-looking statements. They are based on management's beliefs and assumptions and on information available to management only as of the date of this conference call. Our actual results could differ materially from those anticipated in these forward-looking statements for many reasons, including, without limitation, the factors described ...